Forward Pharma As (FWP) 20-F Annual Report April 2017

Compare this 20-F Annual Report to its predecessor by reading our highlights to see what text and tables were ~~removed~~ , added and changed by Forward Pharma As.

Continue

Assess how Forward Pharma As's management team is paid from their Annual Proxy

Forward Pharma As's Definitive Proxy Statement (Form DEF 14A) filed after their 2017 10-K Annual Report includes:

Voting Procedures
Board Members
Executive Team
Salaries, Bonuses, Perks
Peers / Competitors

Continue

Material Contracts, Statements, Certifications & more

Forward Pharma As provided additional information to their SEC Filing as exhibits

Exhibit 1.1: Underwriting Agreement

Exhibit 4.6: Instruments Defining The Rights Of Security Holders, Including Indentures

Exhibit 12.1: Statement Regarding Calculation Of Ratios

Exhibit 12.2: Statement Regarding Calculation Of Ratios

Exhibit 13.1: Report To Security Holders

Exhibit 13.2: Report To Security Holders

Exhibit 23.1: Consents Of Experts And Counsel

Ticker: FWP
CIK: 1604924
Form Type: 20-F Annual Report
Accession Number: 0001047469-17-002703
Submitted to the SEC: Tue Apr 18 2017 5:21:27 PM EST
Accepted by the SEC: Tue Apr 18 2017
Period: Saturday, December 31, 2016
Industry: Pharmaceutical Preparations